In this video interview, David Morton, PhD, director of biostatistics at Certara, explains how regulatory momentum is ...
Clinical Trials Arena on MSN
The Bayesian challenge: complexity that pays off
The FDA has released draft guidance on how sponsors can use Bayesian models for clinical trials.
As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...
The FDA has opened the door to the use of Bayesian statistical methods in clinical trials. The worry: Introducing subjectivity into what should be an objective process.
I like Bayesian statistics but I hate the way they are being forced upon us as the only way of knowing God. And I think frequentist statistics have much to recommend themselves, even when embedded in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results